Fabien Richaud
Director, Patents
Nice
After completing a Masters degree in Pharmacology and an MSc in biochemistry at the University of Nice, Fabien Richaud did a six-month internship at leading French IP Firm Cabinet Lavoix in Lyon. While there, he acquired the basics in patent-related matters.
Fabien joined Murgitroyd in 2005 after obtaining qualifications in patents, trade marks and designs at the “International Centre of Intellectual Property of Strasbourg” (CEIP) and a first experience as an in-house patent specialist in an international pharmaceutical company. Fabien quickly qualified as a European Patent Attorney.
Fabien has experience of drafting and prosecuting patents in various technical fields (see “Core Technical Expertise” below), providing assistance in managing international patent portfolios (and, if required, acting as in-house Patent Counsel for his clients), preparing legal opinions (e.g. patentability and Freedom to Operate opinions), helping client with patent acquisition/selling/in- and out-licenses, handling opposition and appeal proceedings before the EPO and French litigation proceedings.
- Food supplements
- Galenic formulations
- Cosmetics
- Perfumes and fragrances
- Nutraceuticals
- Herbal medicines
- Microbiology
- In vitro diagnostics
- Veterinary drugs and food supplements
- Medical devices
- Biomedical
- Biotechnology
- Genetic engineering
- Dermatology
- Organic Chemistry
- Pharmaceuticals & therapeutics
- Microorganism protection
- Food Science
Key contributor to our Life Sciences & Healthcare Team awarded Gold by the Financial Times
Financial Times European Leading Patent Law Firms, combined Pharmaceuticals, Biotechnology, Food & Healthcare awards - 2019, 2020, 2022, 2023 & 2024
Mike, Fabien, thanks for handling the twists and turns of the hearing so well. Thank you for your input at an important moment. I really appreciate it and the outcome is very good for our company.
Senior Patent Counsel, Pioneering diagnostics Company
Great job at the oral hearing and with all of the preparations that went into this. This is a great outcome!
US based biotechnology Company
